Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

Condition:   Advanced Liver Cancer Interventions:   Drug: PD-1;   Drug: Sorafenib Sponsor:   Guangxi Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials